Akero(AKRO) Newsfilter·2025-02-20 13:42Akero Therapeutics, Inc. (NASDAQ:AKRO) - Grabar Law Office is investigating whether certain officers and directors of Akero breached their fiduciary duties owed to the company [1] - A securities fraud class action complaint alleges that Akero made false and misleading statements regarding the SYMMETRY study, including that approximately 20% of enrolled patients had cryptogenic cirrhosis and did not have definitive NASH at baseline [3] - The complaint also claims that the results from cryptogenic cirrhosis patients were to be excluded from the calculation of NASH resolution secondary endpoints, and that Akero introduced a confounding factor into the study's design [3] - Akero allegedly misrepresented the nature of the SYMMETRY trial and its usefulness in supporting any new drug application, impacting the likelihood of EFX becoming a commercial treatment for NASH cirrhotics [3] Crocs, Inc. (NASDAQ:CROX) - Grabar Law Office is investigating claims on behalf of shareholders of Crocs, Inc. regarding potential breaches of fiduciary duties by certain officers and directors [5] - A securities fraud class action complaint alleges that Crocs made materially false and misleading statements about the nature and sustainability of HEYDUDE's revenue growth following its acquisition [7] - The complaint indicates that the revenue growth was driven by stocking third-party wholesalers and retailers, and that destocking of excess inventory negatively impacted financial results [8] Extreme Networks, Inc. (NASDAQ:EXTR) - Grabar Law Office is investigating claims on behalf of Extreme Networks shareholders concerning potential breaches of fiduciary duties by certain officers [10] - A securities fraud class action complaint alleges that Extreme Networks made false and misleading statements regarding adverse client demand trends and the fulfillment of backlog orders [12] - The complaint states that Extreme Networks was drawing down its backlog at a faster rate than represented, leading to a misrepresentation of organic demand, revenue growth, and market share gains [12] Domino's Pizza, Inc. (NASDAQ:DPZ) - Grabar Law Office is investigating claims on behalf of Domino's shareholders regarding potential breaches of fiduciary duties by certain officers [14] - A securities fraud class action complaint alleges that Domino's made materially false and misleading statements about its business and financial prospects, particularly concerning challenges faced by its largest master franchisee [16] - The complaint suggests that Domino's was unlikely to meet its previously issued long-term guidance for annual global net store growth, leading to overstated business prospects [16]